Masimo Corporation (0JZ2.L)
0JZ2.L Stock Price Chart
Explore Masimo Corporation interactive price chart. Choose custom timeframes to analyze 0JZ2.L price movements and trends.
0JZ2.L Company Profile
Discover essential business fundamentals and corporate details for Masimo Corporation (0JZ2.L) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Medical - Equipment & Services
IPO Date
29 Jan 2018
Employees
3.60K
Website
https://www.masimo.comCEO
Catherine M. Szyman
Description
Masimo Corporation develops, manufactures, and markets noninvasive monitoring technologies and hospital automation solutions worldwide. The company offers masimo signal extraction technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry. It also provides Masimo rainbow SET platform that includes rainbow SET Pulse CO-Oximetry products that noninvasively monitor hemoglobin species, including oxygen saturation, pulse rate, perfusion index, pleth variability index, and respiration rate from the pleth; noninvasively monitor hemoglobin concentration, and carboxyhemoglobin and methemoglobin; monitor arterial oxygen saturation and acoustic respiration rate; and calculates oxygen content and oxygen reserve index. It offers SedLine brain function monitoring technology to measure the brain's electrical activity by detecting EEG signals; capnography and gas monitoring products comprising external plug-in-and-measure capnography and gas analyzers, integrated modules, handheld capnograph and capnometer devices, and capnography sampling lines; O3 regional oximetry for tissue oxygen saturation measurement; and hemodynamic monitoring solutions. Its Masimo Hospital Automation platform includes Patient SafetyNet, Patient SafetyNet surveillance, Kite, UniView, Replica, UniView : 60, and MyView. It offers connectivity devices; and nasal high flow ventilation and neuromodulation solutions. It provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers; and non-medical/consumer products through e-commerce site, masimopersonalhealth.com. The company was incorporated in 1989 and is headquartered in Irvine, California.
0JZ2.L Financial Timeline
Browse a chronological timeline of Masimo Corporation corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 3 Nov 2025
Upcoming earnings on 4 Aug 2025
Revenue estimate is $368.65M.
Earnings released on 6 May 2025
EPS came in at $1.36 surpassing the estimated $1.21 by +12.40%, while revenue for the quarter reached $372.00M, beating expectations by +1.14%.
Earnings released on 25 Feb 2025
EPS came in at -$6.52 falling short of the estimated $1.43 by -556.11%, while revenue for the quarter reached $600.70M, beating expectations by +1.24%.
Earnings released on 6 Nov 2024
EPS came in at $0.18 falling short of the estimated $0.84 by -78.43%, while revenue for the quarter reached $504.60M, missing expectations by -14.70%.
Earnings released on 7 Aug 2024
EPS came in at $0.29 falling short of the estimated $0.77 by -61.48%, while revenue for the quarter reached $496.30M, beating expectations by +0.48%.
Earnings released on 8 May 2024
EPS came in at $0.35 falling short of the estimated $0.70 by -50.47%, while revenue for the quarter reached $492.80M, beating expectations by +1.05%.
Earnings released on 6 Mar 2024
EPS came in at $0.63 falling short of the estimated $0.90 by -29.90%, while revenue for the quarter reached $548.90M, beating expectations by +0.59%.
Earnings released on 8 Nov 2023
EPS came in at $0.20 falling short of the estimated $0.61 by -67.54%, while revenue for the quarter reached $478.90M, missing expectations by -3.04%.
Earnings released on 9 Aug 2023
EPS came in at $0.29 falling short of the estimated $0.64 by -54.98%, while revenue for the quarter reached $455.30M, missing expectations by -4.80%.
Earnings released on 8 Jun 2023
EPS came in at $0.39 falling short of the estimated $0.84 by -53.11%, while revenue for the quarter reached $565.00M, beating expectations by +1.28%.
Earnings released on 1 Mar 2023
EPS came in at $0.76 falling short of the estimated $1.18 by -35.93%, while revenue for the quarter reached $617.00M, beating expectations by +2.41%.
Earnings released on 1 Oct 2022
EPS came in at $0.70 falling short of the estimated $0.92 by -24.13%, while revenue for the quarter reached $549.30M, beating expectations by +2.70%.
Earnings released on 2 Jul 2022
EPS came in at $0.33 falling short of the estimated $1.20 by -72.73%, while revenue for the quarter reached $565.30M, beating expectations by +4.58%.
Earnings released on 25 Apr 2022
EPS came in at $0.81 falling short of the estimated $0.90 by -9.67%, while revenue for the quarter reached $304.24M, missing expectations by -1.23%.
Earnings released on 15 Feb 2022
EPS came in at $1.18 surpassing the estimated $1.10 by +7.27%, while revenue for the quarter reached $327.58M, beating expectations by +2.20%.
Earnings released on 26 Oct 2021
EPS came in at $0.88, while revenue for the quarter reached $305.12M.
Earnings released on 2 Oct 2021
EPS came in at $1.00, while revenue for the quarter reached $307.41M.
Earnings released on 3 Apr 2021
EPS came in at $0.92, while revenue for the quarter reached $299.04M.
Earnings released on 2 Jan 2021
EPS came in at $1.21, while revenue for the quarter reached $295.05M.
Earnings released on 26 Sept 2020
EPS came in at $0.85, while revenue for the quarter reached $278.11M.
0JZ2.L Stock Performance
Access detailed 0JZ2.L performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.